Do clinical manifestations of resistance to thyroid hormone correlate with the functional alteration of the corresponding mutant thyroid hormone-beta receptors?

Journal of Clinical Endocrinology and Metabolism

Volumn 80, Issue 11, 1995, Pages 3246-3256

  Hayashi, Yoshitaka ^a   Weiss, Roy E ^a   Sarne, David H ^a,d   Yen, Paul M ^b   Sunthornthepvarakul, Thongkum ^a   Marcocci, Claudio ^c   Chin, William W ^b   Refetoff, Samuel ^a  

^a UNIVERSITY OF CHICAGO   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c UNIVERSITY OF PISA   (Italy)

^d UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR; THYROID HORMONE RECEPTOR;

ADULT; ARTICLE; GENE MUTATION; GENETIC REGULATION; GENETIC TRANSCRIPTION; HORMONE BINDING; HORMONE RESISTANCE; HORMONE RESPONSE; HUMAN; LIGAND BINDING; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROTEIN DOMAIN; RECEPTOR GENE; TRANSACTIVATION;

ADOLESCENT; ADULT; BASE SEQUENCE; BINDING, COMPETITIVE; CHILD; CHILD, PRESCHOOL; FEMALE; HUMAN; MALE; MIDDLE AGE; MOLECULAR SEQUENCE DATA; MUTATION; OLIGONUCLEOTIDE PROBES; OSMOLAR CONCENTRATION; RECEPTORS, THYROID HORMONE; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; THYROID HORMONE RESISTANCE SYNDROME; THYROXINE; TRIIODOTHYRONINE;

EID: 0028871978     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jcem.80.11.7593433     Document Type: Article

References (40)

1. Evans RM. 1988 The steroid and thyroid hormone receptor superfamily. Science. 240:889-895.
2. Refetoff S, Weiss RE, Usala SJ. 1993 The syndromes of resistance to thyroid hormone. Endocr Rev. 14:348-399.
3. Refetoff S, Weiss RE, Usala SJ, Hayashi Y. 1994 The syndromes of resistance to thyroid hormone: update 1994. Bethesda: The Endocrine Society; 336-343.
4. Mixson AJ, Parrilla R, Ransom SC, et al. 1992 Correlations of language abnormalities with localization of mutations in the β-thyroid hormone receptor in 13 kindreds with generalized resistance to thyroid hormone: identification of four new mutations. J Clin Endocrinol Metab. 75:1039-1045.
5. Hayashi Y, Janssen OE, Weiss RE, Murata Y, Seo H, Refetoff S. 1993 The relative expression of mutant and normal thyroid hormone receptor genes in patients with generalized resistance to thyroid hormone determined by estimation of their specific messenger ribonucleic acid products. J Clin Endocrinol Metab. 76:64-69.
6. Weiss RE, Weinberg M, Refetoff S. 1993 Identical mutations in unrelated families with generalized resistance to thyroid hormone occur in cytosine-guanine-rich areas of the thyroid hormone receptor beta gene. J Clin Invest. 91:2408-2415.
7. Beck-Peccoz P, Chatterjee VKK, Chin WW, et al. 1993 Nomenclature of thyroid hormone receptor β-gene mutations in resistance to thyroid hormone: consensus statement from the first workshop on thyroid hormone resistance, July 10-11, 1993, Cambridge, United Kingdom. J Clin Endocrinol Metab. 78:990-993.
8. Sarne DH, Refetoff S, Rosenfield RL, Farriaux JP. 1988 Sex-hormone binding globulin in the diagnosis of peripheral tissue resistance to thyroid hormone: the value of changes following short-term triiodothyronine administration. J Clin Endocrinol Metab. 66:740-746.
9. Sakurai A, Takeda K, Ain K, eta!. 1989 Generalized resistance to thyroid hormone associated with a mutation in the ligand-binding domain of the human thyroid hormone receptor β. Proc Natl Acad Sci USA. 86:8977-8981.
10. Weiss RE, Marcocci C, Bruno-Bossio G, Refetoff S. 1993 Multiple genetic factors in the heterogeneity of thyroid hormone resistance. J Clin Endocrinol Metab. 76:257-259.
11. Weiss RE, Stein MA, Duck SC, eta!. 1994 Low intelligence but not attention deficit hyperactivity disorder is associated with resistance to thyroid hormone caused by mutation R316H in the thyroid hormone receptor β gene. J Clin Endocrinol Metab. 78:1525-1528.
12. Takeda K, Weiss RE, Refetoff S. 1992 Rapid localization of mutations in the thyroid hormone receptor-β gene by denaturing gradient gel electrophoresis in 18 families with thyroid hormone resistance. J Clin Endocrinol Metab. 74:712-719.
13. Refetoff S, Salazar A, Smith TJ, Scherberg NH. 1983 The consequences of inappropriate treatment due to failure to recognize the syndrome of pituitary and peripheral tissue resistance to thyroid hormone. Metabolism. 32:822-834.
14. Moll GW, Rosenfield RL, Helke JH. 1981 Estradiol-testosterone binding interactions and free plasma estradiol under physiological conditions. J Clin Endocrinol Metab. 52:868-874.
15. Hayashi Y, Sunthomthepvarakul T, Refetoff S. 1994 Mutations of CpG dinucleotides located in the triiodothyronine (T 3)-binding domain of the thyroid hormone receptor (TR) β gene that appears to be devoid of natural mutations may not be detected because they are unlikely to produce the clinical phenotype of resistance to thyroid hormone. J Clin Invest. 94:607-615.
16. Nagaya T, Madison LD, Jameson JL. 1992 Thyroid hormone receptor mutants that cause resistance to thyroid hormone: evidence for receptor competition for DNA sequences in target genes. J Bioi Chern. 267:13014-13019.
17. Narr AM, Boutin JM, Lipkin SM, eta!. 1991 The orientation and spacing of core DNA-binding motifs dictate selective transcriptional responses to three nuclear receptors. Cell. 65:1267-1279.
18. Samuels HH, Stanley F, Casanova J. 1979 Depletion of L-3,5,3'triiodothyronine and L-thyroxine in euthyroid calf serum for use in cell culture studies of the action ofthyroid hormone. Endocrinology. 105:80-85.
19. Graham FL, Vander Eb AJ. 1973 A new technique for the assay of infectivity of human adenovirus 5 DNA. Virology. 52:456-467.
20. Yen PM, Sugawara A, Refetoff S, Chin WW. 1992 New insights on the mechanism(s) of the dominant negative effect of mutant thyroid hormone receptor in generalized resistance to thyroid homone. J Clin Invest. 90:1825-1831.
21. Inoue A, Yamakawa J, Yukioka M, Morisawa S. 1983 Filter-binding assay procedure for thyroid hormone receptors. Anal Biochem. 134: 176-183.
22. Flynn TR, Hollenberg AN, Cohen O, eta!. 1994 A novel C-terminal domain in the thyroid hormone receptor selectively mediates thyroid hormone inhibition. J Bioi Chern. 629:32713-32716.
23. Adams M, Matthews C, Collingwood TN, Tone Y, Beck-Peccoz P, Chatterjee VKK. 1994 Genetic analysis of 29 kindreds with generalized and pituitary resistance to thyroid hormone. Identification of thirteen novel mutations in the thyroid hormone receptor beta gene. J Clin Invest. 94:506-515.
24. Geffner ME, Su F, Ross NS, et a!. 1993 An arginine to histidine mutation in codon 311 of the c-erbAβ gene results in a mutant thyroid hormone receptor that does not mediate a dominant negative phenotype. J Clin Invest. 91:538-546.
25. Zavacki AM, Harney JW, Brent GA, Larsen PR. 1993 Dominant negative inhibition by mutant thyroid hormone receptors is thyroid hormone response element and receptor isoform specific. Mol Endocrinol. 7:1319-1330.
26. Usala SJ, Tennyson GE, Bale AE, eta!. 1990 A base mutation of the c-erbAΒ thyroid hormone receptor in a kindred with generalized thyroid hormone resistance. J Clin Invest. 85:93-100.
27. Mixson AJ, Hauser P, Tennyson G, Renault JC, Bodenner DL, Weintraub BD. 1993 Differential expression of mutant and normal beta T3 receptor alleles in kindreds with generalized resistance to thyoid hormone. J Clin Invest. 91:2296-2300.
28. Parrilla R, Mixson AJ, MaPherson J, McClaskey JH, Weintraub BD. 1991 Characterization of seven novel mutations of the c-erbAΒ gene in unrelated kindreds with generalized thyroid hormone resistance: evidence for two "hot spot" regions of the ligand binding domain. J Clin Invest. 88:2123-2130.
29. Nagaya T, Ebefhardt NL, Jameson JL. 1993 Thyroid hormone resistance syndrome: correlation of dominant negative activity and location of mutations. J Clin Endocrinol Metab. 77:982-990.
30. Beck-Peccoz P, Chatterjee VKK. 1994 The variable clinical phenotype in thyroid hormone resistance syndrome. Thyroid. 4:225-232.
31. Weintraub BD, Gershengom MC, Kourides IA, Fein H. 1981 Inappropriate secretion of thyroid stimulating hormone. Ann Intern Med. 95:339-351.
32. Hao E, Menke JB, Smith AM, eta!. 1994 Divergent dimerization properties of mutant β1 thyroid hormone receptors are associated with different dominant negative activities. Mol Endocrinol. 8:841-851.
33. Mixson AJ, Renault JC, Ransom S, Bodenner DL, Weintraub BD. 1993 Identification of a novel mutation in the gene encoding the β-triiodothyronine receptor in a patient with apparent selective pituitary resistance to thyroid hormone. Clin Endocrinol OxD. 38: 227-234.
34. Kurokawa R, Direnzo J, Boehm M, eta!. 1994 Regulation of retinoid signaling by receptor polarity and allosteric control of ligand binding. Nature. 371:528-531.
35. Schrader M, Muller KM, Nayeri S, Kahlen J-P, Carlberg C. 1994 Vitamin D3-thyroid hormone receptor heterodimer polarity directs ligand sensitivity of transactivation. Nature (Lond). 370:382-386.
36. Meier CA, Parkinson C, Chen A, et a!. 1993 Interaction of human Β1 thyroid hormone receptor and its mutants with DNA and retinoid X receptor. T3 response element-dependent dominant negative potency. J Clin Invest. 92:1986-1993.
37. Nagaya T, Jameson JL. 1993 Thyroid hormone receptor dimerization is required for dominant negative inhibition by mutations that cause thyroid hormone resistance. J Bioi Chern. 268:15766-15771.
38. Collingwood TN, Adams M, Tone Y, Chatterjee VKK. 1994 Spectrum of transcriptional, dimerization, and dominant negative properties of twenty different mutant thyroid hormone β-receptors in thyroid hormone resistance syndrome. Mol Endocrinol. 8:1262-1277.
39. Au-Fliegner M, Helmer E, Casanova J, Raaka BM, Samuels HT. 1993 The conserved ninth C-terminal heptad in thyroid hormone and retinoic acid receptors mediates diverse responses by affecting heterodimer but not homodimer formation. Mol Cell Bioi. 13:5725-5737.
40. A registry for resistance to Thyroid Hormone. 1994 J Clin Endocrinol Metab. 79:1560 (Announcement).